Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-10-30 00:00:00 ET · period of report 2025-10-28 · accession 0001835458-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-30 | 2025-10-28 | KNSA | Ragosa Mark | CFO | M - OptEx | $30.93 | +100 | 31.2K | +0.3% | +$3,093 |
| D | 2025-10-30 | 2025-10-28 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $41.00 | -100 | 31.1K | -0.3% | -$4,100 |
| D | 2025-10-30 | 2025-10-28 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -100 | 19.9K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-10-28 | M | A | 100 | $30.93 | 31,186 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-10-28 | S | D | 100 | $41.00 | 31,086 | D | — | — | |
| 3 | Derivative | Share Option | 2025-10-28 | M | D | 100 | $0.00 | 19,900 | D | $30.93 · — to 2028-09-19 | 100 Class A Ordinary Share | (F2) The option is fully vested and exercisable. |